BioNTech - Yahoo Search Results

- BioNTech expects Omicron-adapted vaccine deliveries as soon as October
  Fox News· 1 hour ago
  BioNTech is expected to be making deliveries of two Omicron-adapted vaccines as soon as October,...
- BioNTech SE ADR falls Monday, underperforms market
  Market Watch· 18 hours ago
  The BioNTech SE ADR shed 7.54% to $169.30 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...
- Is BioNTech SE's (NASDAQ:BNTX) Latest Stock Performance A Reflection Of Its Financial Health?
  Simply Wall St. via Yahoo Finance· 3 hours ago
  Most readers would already be aware that BioNTech's (NASDAQ:BNTX) stock increased significantly by...
- BioNTech reports strong first half, expects demand to grow
  WTAJ-TV Altoona· 1 day ago
  BERLIN (AP) — BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has...
- Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech...
  Forbes· 1 day ago
  Pfizer and BioNTech will begin trials of their updated mRNA Covid-19 vaccine designed to protect...
- Why BioNTech Was a Sickly Stock on Monday | The Motley Fool
  The Motley Fool· 19 hours ago
  BioNTech (BNTX -7.54%), the out-of-nowhere German biotech that shot to prominence with the...
- BioNTech's (BNTX) Earnings & Revenues Miss Estimates in Q2
  Zacks via Yahoo Finance· 1 day ago
  Germany-based BioNTech SE BNTX is an immunotherapy company that focuses on the development of novel...
- BioNTech Q2 Results Down, Backs FY22 Vaccine Revenue View; Stock Down
  RTT News· 1 day ago
  Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5...
- BioNTech Dives As Pfizer Partner Reports Lagging Covid Vaccine Sales, Guidance
  Investor's Business Daily· 18 hours ago
  German Covid vaccine developer BioNTech lagged second-quarter estimates and reiterated disappointing...
- BioNTech Earnings Shocker: Posts Lower Than Expected Q2 Profits, Revenues Fall
  Benzinga via Yahoo Finance· 1 day ago
  BioNTech SE (NASDAQ: BNTX) has reported Q2 FY22 revenues of €3.19 billion, down from €5.3 billion a...